Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
01
2019
accepted:
05
10
2019
entrez:
25
10
2019
pubmed:
28
10
2019
medline:
20
3
2020
Statut:
epublish
Résumé
Differences in breast cancer survival by race and ethnicity are often assumed to be a fairly recent phenomenon, and are hypothesized to have arisen due to gaps in receipt of screening or therapy. The emergence of these differences in calendar time have implications for identification of their origin. We sought to determine whether breast cancer survival differences by race or ethnicity arose in tandem with the advent of screening or therapeutic advances. A cohort of women diagnosed with invasive breast cancer from 1975-2009 in 18 population-based registries were followed for five-year breast cancer cause-specific survival. Differences in survival according to race/ethnicity and estrogen receptor status were quantified in Cox proportional hazards models, with estimation of hazard ratios (HR), 95% confidence intervals (CI), and absolute risk differences. For 2010, we also assessed differences in survival by breast cancer subtypes defined by hormone receptor and Her2/neu status. Among over 930,000 women, initial differences in five-year breast cancer-specific survival by race became apparent among 1975-1979 diagnoses and continued to be evident, with stronger disparities apparent in those of Black vs. White Non-Hispanic (WNH) race and among estrogen-receptor positive vs. negative disease. Within breast cancer subtype, all included race/ethnic groups experienced disparate survival in comparison with WNH women for triple-negative disease. Black women had a consistent gap in absolute survival of .10-.12, compared with WNH women, from 1975-1979 through all included time periods, such that 5- year survival of Black women diagnosed in 2005-09 lagged more than 20 years behind that of WNH women. Survival differed by race for diagnoses that predate the introduction of mammographic screening and most therapeutic advances. Absolute differences in survival by race and ethnicity have remained almost constant over 40 years of observation, suggesting early origins for some contributors.
Identifiants
pubmed: 31647839
doi: 10.1371/journal.pone.0224064
pii: PONE-D-19-00118
pmc: PMC6812853
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0224064Subventions
Organisme : NCI NIH HHS
ID : P30 CA118100
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA132877
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA163890
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA194496
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Oncol. 2003 Feb 15;21(4):602-6
pubmed: 12586795
JAMA Oncol. 2016 Oct 1;2(10):1326-1332
pubmed: 27281650
J Natl Cancer Inst. 2012 Mar 7;104(5):406-14
pubmed: 22250182
J Clin Oncol. 2015 Mar 20;33(9):1053-9
pubmed: 25691670
JAMA. 2013 Jul 24;310(4):376-7
pubmed: 23917286
Clin Cancer Res. 2010 Dec 15;16(24):6100-10
pubmed: 21169259
JAMA Oncol. 2017 Dec 1;3(12):1654-1662
pubmed: 28472234
JAMA. 2013 Jul 24;310(4):389-97
pubmed: 23917289
J Clin Oncol. 2010 Sep 20;28(27):4120-8
pubmed: 20585090
CA Cancer J Clin. 2017 Nov;67(6):439-448
pubmed: 28972651
Arch Pathol Lab Med. 2010 Jul;134(7):e48-72
pubmed: 20586616
Breast Cancer Res Treat. 2018 Jul;170(2):405-414
pubmed: 29569018
J Clin Oncol. 2015 Jul 10;33(20):2254-61
pubmed: 25964252
J Clin Oncol. 2016 Dec 20;34(36):4398-4404
pubmed: 27998232
J Clin Oncol. 2009 May 1;27(13):2157-62
pubmed: 19307504
JAMA. 2015 Jan 13;313(2):165-73
pubmed: 25585328
J Natl Cancer Inst. 2009 Jul 15;101(14):984-92
pubmed: 19584328
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):112-22
pubmed: 21119071
BMC Cancer. 2013 May 04;13:225
pubmed: 23642215